Institutional investors hold a majority ownership of PCRX through the 109.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2016, these large investors purchased a net $2.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CUTLER GROUP LP Bought 14.9 Thousand shares of Pacira Pharmaceuticals In...